Related Experiment Videos
The growth kinetics of clonogenic tumor cells that survive radiation therapy
1Department of Radiation Oncology, Stanford University School of Medicine, CA 94305.
Progress in Clinical and Biological Research
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interleukin 1 increases thymidine labeling index of normal tissues of mice but not the tumor.
International journal of radiation oncology, biology, physics·1994
The importance of schedule and drug dose intensity in combinations of modalities.
International journal of radiation oncology, biology, physics·1994
Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor.
International journal of radiation oncology, biology, physics·1993
Reoxygenation in the RIF-1 tumor after chemotherapy.
International journal of radiation oncology, biology, physics·1992
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
Combined Maximum Tolerated Activity and Lesion-based Dosimetry for Personalized Radioiodine Therapy in Metastatic Differentiated Thyroid Carcinoma: An Early Institutional Experience.
Molecular imaging and radionuclide therapy·2026